Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
Renal sympathetic denervation (RDN) has been and is still proposed as a new treatment modality in patients with apparently treatment resistant hypertension (TRH), a condition defined as persistent blood pressure elevation despite prescription of at least 3 antihypertensive drugs including a diuretic...
Main Authors: | Sverre Erik Kjeldsen, Fadl Elmula M. Fadl Elmula, Anne Cecilie Larstorp, Alexandre ePersu, Yu eJin, Jan A. Staessen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-02-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphys.2015.00009/full |
Similar Items
-
Renal sympathetic denervation for treatment of drug-resistant hypertension one-year results from the Symplicity HTN-2 randomized, controlled trial
by: Arup Dasbiswas
Published: (2013-03-01) -
ENDOVASCULAR TREATMENT OF THE RESIDUAL THROMBOEMBOLIC PULMONARY HYPERTENSION AFTER PULMONARY THROMBENDARTERECTOMY WITH THE DENERVATION SYSTEM SYMPLICITY
by: B. A. Rudenko, et al.
Published: (2018-04-01) -
A Clinician’s Perspective of Renal Sympathetic Nerve Contribution to Hypertension
by: Alexandros eBriasoulis, et al.
Published: (2015-03-01) -
Radiofrequency renal arteries denervation: effectively and safely
by: V A Grigin, et al.
Published: (2016-12-01) -
Radiofrequency renal arteries denervation: effectively and safely
by: Grigin V.A., et al.
Published: (2016-12-01)